Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC)

CUSIP: 23254L801

Q4 2023 13F Holders as of 31 Dec 2023

Security identity 2 facts
Security type / class
Equity / Common Stock, $0.001 par value
Shares outstanding
1,584,707
Holder snapshot 7 facts
Total 13F shares
93,921
Share change
+93,921
Total reported value
$249,543
Reported price per share
$2.67
Number of holders
13
Value change
+$249,543
Number of buys
13

Security key

23254L801

Report period

Q4 2023

Institutions

13

Top holders

10

CYCC full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2024 Bio Green Med Solution, Inc. SEC filings Bio Green Med Solution, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Spiro George Rombotis
13D/G signal
—
Evidence rows
15
Latest as of
21 Dec 2023
3/4/5 13F Highest disclosed value: $227,601 Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Spiro George Rombotis
3/4/5
President and CEO, Director
3/4/5
—
mixed-class rows
$227,601
184,728 shares
mixed-class rows
 — 21 Dec 2023
Kenneth M. Ferguson
3/4/5
Director
3/4/5
—
mixed-class rows
$149,016
87,390 shares
mixed-class rows
 — 30 Jun 2023
Karin L. Walker
3/4/5
Director
3/4/5
—
mixed-class rows
$134,596
83,040 shares
mixed-class rows
 — 30 Jun 2023
Sam L. Barker
3/4/5
Director
3/4/5
—
mixed-class rows
$133,976
82,853 shares
mixed-class rows
 — 30 Jun 2023
Christopher S. Henney
3/4/5
Director
3/4/5
—
mixed-class rows
$130,661
81,853 shares
mixed-class rows
 — 30 Jun 2023
Robert J. Spiegel
3/4/5
Director
3/4/5
—
mixed-class rows
$130,661
81,853 shares
mixed-class rows
 — 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
13
Shares
93,921
Rows available
13
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2023 vs Q2 2025 Across Filers

Q2 2025 holders
0
Q4 2023 holders
13
Holder diff
13
Investor Q2 2025 Shares Q4 2023 Shares Share Diff Share Chg % Q2 2025 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .